デフォルト表紙
市場調査レポート
商品コード
1576514

3Dバイオプリンティング市場:製品別(バイオプリンター、バイオインク、材料、ソフトウェア、アクセサリー)、用途別(がん研究、組織工学、創薬)、エンドユーザー別 - 2030年までの世界予測

3D Bioprinting Market by Product (Bioprinter, Bioinks, Materials, Software, Accessories) Application (Cancer Research, Tissue Engineering, Drug Discovery) End User - Global Forecast to 2030


出版日
ページ情報
英文 250 Pages
納期
5~7営業日
カスタマイズ可能
3Dバイオプリンティング市場:製品別(バイオプリンター、バイオインク、材料、ソフトウェア、アクセサリー)、用途別(がん研究、組織工学、創薬)、エンドユーザー別 - 2030年までの世界予測
出版日: 2024年08月01日
発行: Meticulous Research
ページ情報: 英文 250 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示

  • 概要
  • 図表
  • 目次
概要

3Dバイオプリンティング市場は、2024年から2030年までのCAGRが17.1%で、2030年までには52億1,000万米ドルに達すると予測されています。

広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、課題、機会の分析で構成されています。この成長は、3Dバイオプリンティングの技術的進歩、慢性疾患の負担増と相まって高齢者人口が増加していること、研究開発投資の増加によるものです。しかし、熟練した専門家の不足と3Dバイオプリンティングに関連する高コストがこの市場の成長を抑制しています。

さらに、臓器移植の需要の増加は、この市場で事業を展開するプレーヤーに成長機会をもたらすと期待されています。しかし、3Dバイオプリンティング製品の使用に関連する知的財産権や安全性に関する懸念は、市場成長に影響を与える大きな課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

  • 概要
  • 促進要因
    • 3Dバイオプリンティングの技術的進歩
    • 高齢者人口の増加と慢性疾患の負担増
    • 研究開発投資の増加
  • 抑制要因
    • 熟練した専門家の不足
    • 3Dバイオプリンティングに関連する高コスト
  • 機会
    • 臓器移植の需要の増加
  • 課題
    • 知的財産権に関する懸念
    • 3Dバイオプリント製品の使用に伴う安全性の問題
  • 要因分析
  • 価格分析
  • 技術動向
  • 規制分析
  • ポーターのファイブフォース分析

第5章 3Dバイオプリンティング市場の評価:製品別

  • 概要
  • バイオプリンター
    • インクジェットベース
    • 押出ベース
    • ステレオリソグラフィー(SLA)
    • レーザーベース
    • 溶融堆積モデリング(FDM)
    • 選択的レーザー焼結(SLS)
    • その他の技術
  • バイオインク
    • 天然
    • 合成
    • ハイブリッド
  • 材料
    • ハイドロゲル
    • 生体細胞
    • 細胞外マトリックス
    • バイオマテリアル
    • その他の材料
  • ソフトウェア
  • アクセサリーと消耗品

第6章 3Dバイオプリンティング市場の評価:用途別

  • 概要
  • がん研究
  • 再生医療
  • 創薬と試験
  • 組織工学
  • バイオマテリアル・細胞研究
  • その他の用途

第7章 3Dバイオプリンティング市場の評価:エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • CRO(医薬品開発業務受託機関)

第8章 3Dバイオプリンティング市場の評価:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ベルギー
    • スイス
    • オランダ
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ

第9章 競合分析

  • 概要
  • 主要成長戦略
  • 競合ベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 先行企業
    • 新興企業
  • 市場シェア分析 / 市場ランキング:主要企業別(2022年)

第10章 企業プロファイル(事業概要、財務概要、製品ポートフォリオ、戦略的展開、SWOT分析*)

  • Organovo Holdings Inc.
  • BICO Group AB
  • Aspect Biosystems Ltd.
  • Cyfuse Biomedical K.K.
  • Advanced Solutions Life Sciences, LLC
  • CollPlant Biotechnologies Ltd.
  • regenHU Ltd.
  • Poietis
  • REGEMAT 3D, SL
  • 3D Bioprinting Solutions
  • Foldink Life Science Technologies

(注:上位5社のSWOT分析を提供します)

第11章 付録

図表

LIST OF TABLES

  • Table 1 Global 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 2 Global 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 3 Global 3D Bioprinting Market for Bioprinters, by Country/Region, 2022-2030 (USD Million)
  • Table 4 Global Inkjet-based 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 5 Global Extrusion-based 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 6 Global Stereolithography (SLA) 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 7 Global Laser-based 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 8 Global Fused-deposition modeling (FDM) 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 9 Global Selective laser sintering (SLS) 3D Bioprinters Market, by Country/Region, 2022-2030 (USD Million)
  • Table 10 Global 3D Bioprinters Market for Other Technologies, by Country/Region, 2022-2030 (USD Million)
  • Table 11 Global 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 12 Global 3D Bioprinting Market for Bioinks, by Country/Region, 2022-2030 (USD Million)
  • Table 13 Global 3D Bioprinting Market for Natural Bioinks, by Country/Region, 2022-2030 (USD Million)
  • Table 14 Global 3D Bioprinting Market for Synthetic Bioinks, by Country/Region, 2022-2030 (USD Million)
  • Table 15 Global 3D Bioprinting Market for Hybrid Bioinks, by Country/Region, 2022-2030 (USD Million)
  • Table 16 Global 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 17 Global 3D Bioprinting Market for Materials, by Country/Region, 2022-2030 (USD Million)
  • Table 18 Global 3D Bioprinting Market for Hydrogels, by Country/Region, 2022-2030 (USD Million)
  • Table 19 Global 3D Bioprinting Market for Living Cells, by Country/Region, 2022-2030 (USD Million)
  • Table 20 Global 3D Bioprinting Market for Extracellular Matrices, by Country/Region, 2022-2030 (USD Million)
  • Table 21 Global 3D Bioprinting Market for Biomaterials, by Country/Region, 2022-2030 (USD Million)
  • Table 22 Global 3D Bioprinting Market for Other Materials, by Country/Region, 2022-2030 (USD Million)
  • Table 23 Global 3D Bioprinting Market for Software, by Country/Region, 2022-2030 (USD Million)
  • Table 24 Global 3D Bioprinting Market for Accessories and Consumables, by Country/Region, 2022-2030 (USD Million)
  • Table 25 Global 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 26 Global 3D Bioprinting Market for Cancer Research, by Country/Region, 2022-2030 (USD Million)
  • Table 27 Global 3D Bioprinting Market for Regenerative Medicines, by Country/Region, 2022-2030 (USD Million)
  • Table 28 Global 3D Bioprinting Market for Drug Discovery and Testing, by Country/Region, 2022-2030 (USD Million)
  • Table 29 Global 3D Bioprinting Market for Tissue Engineering, by Country/Region, 2022-2030 (USD Million)
  • Table 30 Global 3D Bioprinting Market for Biomaterials and Cells research, by Country/Region, 2022-2030 (USD Million)
  • Table 31 Global 3D Bioprinting Market for Other Applications, by Country/Region, 2022-2030 (USD Million)
  • Table 32 Global 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 33 Global 3D Bioprinting Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2022-2030 (USD Million)
  • Table 34 Global 3D Bioprinting Market for Academic and Research Institutes, by Country/Region, 2022-2030 (USD Million)
  • Table 35 Global 3D Bioprinting Market for Contract Research Organizations (CROs), by Country/Region, 2022-2030 (USD Million)
  • Table 36 Global 3D Bioprinting Market, by Country/Region, 2022-2030 (USD Million)
  • Table 37 North America: 3D Bioprinting Market, by Country, 2022-2030 (USD Million)
  • Table 38 North America: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 39 North America: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 40 North America: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 41 North America: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 42 North America: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 43 North America: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 44 U.S.: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 45 U.S.: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 46 U.S.: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 47 U.S.: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 48 U.S.: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 49 U.S.: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 50 Canada: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 51 Canada: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 52 Canada: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 53 Canada: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 54 Canada: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 55 Canada: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 56 Europe: 3D Bioprinting Market, by Country/Region, 2022-2030 (USD Million)
  • Table 57 Europe: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 58 Europe: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 59 Europe: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 60 Europe: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 61 Europe: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 62 Europe: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 63 Germany: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 64 Germany: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 65 Germany: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 66 Germany: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 67 Germany: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 68 Germany: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 69 France: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 70 France: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 71 France: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 72 France: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 73 France: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 74 France: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 75 U.K.: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 76 U.K.: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 77 U.K.: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 78 U.K.: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 79 U.K.: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 80 U.K.: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 81 Italy: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 82 Italy: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 83 Italy: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 84 Italy: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 85 Italy: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 86 Italy: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 87 Spain: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 88 Spain: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 89 Spain: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 90 Spain: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 91 Spain: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 92 Spain: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 93 Belgium: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 94 Belgium: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 95 Belgium: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 96 Belgium: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 97 Belgium: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 98 Belgium: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 99 Switzerland: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 100 Switzerland: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 101 Switzerland: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 102 Switzerland: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 103 Switzerland: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 104 Switzerland: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 105 Netherlands: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 106 Netherlands: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 107 Netherlands: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 108 Netherlands: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 109 Netherlands: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 110 Netherlands: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 111 Rest of Europe: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 112 Rest of Europe: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 113 Rest of Europe: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 114 Rest of Europe: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 115 Rest of Europe: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 116 Rest of Europe: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 117 Asia-Pacific: 3D Bioprinting Market, by Country/Region, 2022-2030 (USD Million)
  • Table 118 Asia-Pacific: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 119 Asia-Pacific: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 120 Asia-Pacific: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 121 Asia-Pacific: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 122 Asia-Pacific: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 123 Asia-Pacific: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 124 China: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 125 China: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 126 China: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 127 China: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 128 China: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 129 China: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 130 Japan: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 131 Japan: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 132 Japan: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 133 Japan: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 134 Japan: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 135 Japan: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 136 India: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 137 India: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 138 India: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 139 India: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 140 India: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 141 India: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 142 Australia: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 143 Australia: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 144 Australia: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 145 Australia: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 146 Australia: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 147 Australia: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 148 South Korea: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 149 South Korea: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 150 South Korea: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 151 South Korea: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 152 South Korea: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 153 South Korea: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 154 Rest of Asia-Pacific: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 155 Rest of Asia-Pacific: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 156 Rest of Asia-Pacific: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 157 Rest of Asia-Pacific: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 158 Rest of Asia-Pacific: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 159 Rest of Asia-Pacific: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 160 Latin America: 3D Bioprinting Market, by Country/Region, 2022-2030 (USD Million)
  • Table 161 Latin America: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 162 Latin America: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 163 Latin America: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 164 Latin America: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 165 Latin America: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 166 Latin America: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 167 Brazil: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 168 Brazil: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 169 Brazil: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 170 Brazil: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 171 Brazil: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 172 Brazil: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 173 Mexico: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 174 Mexico: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 175 Mexico: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 176 Mexico: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 177 Mexico: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 178 Mexico: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 179 Rest of Latin America: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 180 Rest of Latin America: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 181 Rest of Latin America: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 182 Rest of Latin America: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 183 Rest of Latin America: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 184 Rest of Latin America: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 185 Middle East & Africa: 3D Bioprinting Market, by Product, 2022-2030 (USD Million)
  • Table 186 Middle East & Africa: 3D Bioprinting Market for Bioprinters, by Technology, 2022-2030 (USD Million)
  • Table 187 Middle East & Africa: 3D Bioprinting Market for Bioinks, by Type, 2022-2030 (USD Million)
  • Table 188 Middle East & Africa: 3D Bioprinting Market for Materials, by Type, 2022-2030 (USD Million)
  • Table 189 Middle East & Africa: 3D Bioprinting Market, by Application, 2022-2030 (USD Million)
  • Table 190 Middle East & Africa: 3D Bioprinting Market, by End User, 2022-2030 (USD Million)
  • Table 191 Recent Developments, by Company, 2020-2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global 3D Bioprinting Market, by Product, 2024 VS. 2030 (USD Million)
  • Figure 8 Global 3D Bioprinting Market, by Application, 2024 VS. 2030 (USD Million)
  • Figure 9 Global 3D Bioprinting Market, by End User, 2024 VS. 2030 (USD Million)
  • Figure 10 Global 3D Bioprinting Market, by Geography
  • Figure 11 Impact Analysis: 3D Bioprinting Market
  • Figure 12 Global 3D Bioprinting Market, by Product, 2024 VS. 2030 (USD Million)
  • Figure 13 Global 3D Bioprinting Market, by Application, 2024 VS. 2030 (USD Million)
  • Figure 14 Global 3D Bioprinting Market, by End User, 2024 VS. 2030 (USD Million)
  • Figure 15 Global 3D Bioprinting Market, by Geography, 2024 VS. 2030 (USD Million)
  • Figure 16 North America: 3D Bioprinting Market Snapshot
  • Figure 17 Europe: 3D Bioprinting Market Snapshot
  • Figure 18 Asia-Pacific: 3D Bioprinting Market Snapshot
  • Figure 19 Latin America: 3D Bioprinting Market Snapshot
  • Figure 20 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 21 Global 3D Bioprinting Market: Competitive Benchmarking, by Product
  • Figure 22 Global 3D Bioprinting Market: Competitive Benchmarking, by Geography
  • Figure 23 Global 3D Bioprinting Market: Vendor Dashboard
  • Figure 24 Market Share Analysis: Global 3D Bioprinting Market, 2022
  • Figure 25 Organovo Holdings Inc.: Financial Overview (2022)
  • Figure 26 BICO Group AB: Financial Overview (2022)
  • Figure 27 CollPlant Biotechnologies Ltd.: Financial Overview (2022)
  • Figure 28 Cyfuse Biomedical K.K.: Financial Overview (2022)
目次
Product Code: MRHC - 1041063

3D Bioprinting Market by Product (Bioprinter, Bioinks, Materials [Hydrogels, Cells, Biomaterials], Software), Technology (Inkjet, Extrusion, Laser, SLS), Application (Cancer Research, Tissue Engineering, Drug Discovery), End User-Global Forecast to 2030.

The 3D bioprinting market is projected to reach $5.21 billion by 2030 at a CAGR of 17.1% from 2024 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the technological advancements in 3D bioprinting, the rising geriatric population coupled with the growing burden of chronic diseases, and increasing R&D investments. However, the lack of skilled professionals and high costs associated with 3D bioprinting restrain the growth of this market.

Furthermore, the increasing demand for organ transplantation is expected to generate growth opportunities for the players operating in this market. However, concerns regarding intellectual property rights and safety issues associated with the use of 3D bioprinted products are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the 3D bioprinting market are Organovo Holdings Inc. (U.S.), BICO Group AB (Sweden), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), Advanced Solutions Life Sciences, LLC (U.S.), CollPlant Biotechnologies Ltd. (Israel), regenHU Ltd. (Switzerland), Poietis (France), REGEMAT 3D, SL (Spain), 3DBio Therapeutics (U.S.), and Foldink Life Science Technologies (Armenia).

Among all the products studied in this report, in 2024, the bioprinters segment is expected to account for the largest share of the 3D Bioprinting market. 3D bioprinters produce tissues and organ patches from a patient's cell, which can reduce the chance of rejection, create patient-specific treatment, and reduce the need for animal testing. Further, technological advancements in bioprinters help researchers to focus on various applications and save time and money developing an internal system are the factors that contribute to the large market share of this segment in the 3D bioprinting market.

Among all the applications studied in this report, in 2024, the cancer research segment is expected to account for the largest share of the 3D bioprinting market. The large market share of this segment is attributed to the rising prevalence of cancer. According to GLOBOCAN, in 2020, 19.3 million cancer cases were diagnosed all over the world. The number of cases is expected to increase to 24.5 million by 2030. Cancer models that replicate the tumor microenvironment are produced using 3D bioprinting. This may assist with cancer medication screening and contribute to a greater understanding of cancer.

Among all the end users studied in this report, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the 3D Bioprinting market. The large market share of this segment is attributed to the substantial investments in R&D made by pharmaceutical and biotechnology companies to introduce innovative therapies and treatments. According to the Congressional Budget Office data published in April 2021, the pharmaceutical industry spent USD 83 billion on research and development in 2019, highlighting the significant investment in this field.

An in-depth analysis of the geographical scenario of the 3D bioprinting market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the 3D bioprinting market. In the region in 2024, the U.S. is expected to account for the largest share of the 3D Bioprinting market in North America. The large share of this regional market is attributed to the rapid adoption of 3D bioprinters in various cancer research studies, advanced research infrastructure, and availability of funding to support life science research.

Scope of the Report:

3D Bioprinting Market Assessment-by Product

  • Bioprinters
    • Inkjet-based
    • Extrusion-based
    • Stereolithography (SLA)
    • Laser-based
    • Fused-deposition Modeling (FDM)
    • Selective Laser Sintering (SLS)
    • Other Technologies
  • Bioinks
    • Natural
    • Synthetic
    • Hybrid
  • Materials
    • Hydrogels
    • Living Cells
    • Extracellular Matrices
    • Biomaterials
    • Other Materials
  • Software
  • Accessories and Consumables

(Note 1: Other technologies include Digital Light Processing (DLP), Injection pore filling (IPF), and Injection volume filling (IVF)

Note 2: Other materials include synthetic polymers, composites, and nanocellulose.)

3D Bioprinting Market Assessment-by Application

    • Cancer Research
    • Regenerative Medicines
    • Drug Discovery and Testing
    • Tissue Engineering
    • Biomaterials and cells research
    • Other Applications

Note: Other applications include organ transplantation, tissue, and disease modeling.

3D Bioprinting Market Assessment-by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)

3D Bioprinting Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Technological Advancements in 3D Bioprinting
    • 4.2.2. Rising Geriatric Population, Coupled with the Growing Burden of Chronic Diseases
    • 4.2.3. Increasing R&D Investments
  • 4.3. Restraints
    • 4.3.1. Lack of Skilled Professionals
    • 4.3.2. High Costs Associated with 3D Bioprinting
  • 4.4. Opportunities
    • 4.4.1. Increasing Demand for Organ Transplantation
  • 4.5. Challenges
    • 4.5.1. Concerns Regarding Intellectual Property Rights
    • 4.5.2. Safety Issues Associated With the Use of 3D Bioprinted Products
  • 4.6. Factor Analysis
  • 4.7. Pricing Analysis
  • 4.8. Technology Trends
  • 4.9. Regulatory Analysis
  • 4.10. Porter's Five Forces Analysis

5. 3D Bioprinting Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Bioprinters
    • 5.2.1. Inkjet-based
    • 5.2.2. Extrusion-based
    • 5.2.3. Stereolithography (SLA)
    • 5.2.4. Laser-based
    • 5.2.5. Fused-deposition modeling (FDM)
    • 5.2.6. Selective laser sintering (SLS)
    • 5.2.7. Other Technologies
  • 5.3. Bioinks
    • 5.3.1. Natural
    • 5.3.2. Synthetic
    • 5.3.3. Hybrid
  • 5.4. Materials
    • 5.4.1. Hydrogels
    • 5.4.2. Living Cells
    • 5.4.3. Extracellular Matrices
    • 5.4.4. Biomaterials
    • 5.4.5. Other Materials
  • 5.5. Software
  • 5.6. Accessories and Consumables

6. 3D Bioprinting Assessment-by Application

  • 6.1. Overview
  • 6.2. Cancer Research
  • 6.3. Regenerative Medicines
  • 6.4. Drug Discovery and Testing
  • 6.5. Tissue Engineering
  • 6.6. Biomaterials and cells research
  • 6.7. Other Applications

7. 3D Bioprinting Assessment-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical and Biotechnology Companies
  • 7.3. Academic and Research Institutes
  • 7.4. Contract Research Organizations (CROs)

8. 3D Bioprinting Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Belgium
    • 8.3.7. Switzerland
    • 8.3.8. Netherlands
    • 8.3.9. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. South Korea
    • 8.4.6. Rest of Asia-Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis/Market Rankings, by Key Players (2022)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments, and SWOT Analysis*)

  • 10.1. Organovo Holdings Inc.
  • 10.2. BICO Group AB
  • 10.3. Aspect Biosystems Ltd.
  • 10.4. Cyfuse Biomedical K.K.
  • 10.5. Advanced Solutions Life Sciences, LLC
  • 10.6. CollPlant Biotechnologies Ltd.
  • 10.7. regenHU Ltd.
  • 10.8. Poietis
  • 10.9. REGEMAT 3D, SL
  • 10.10. 3D Bioprinting Solutions
  • 10.11. Foldink Life Science Technologies

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports